tm
Seeing Is Believing
tm
Seeing Is Believing
MRNS is currently covered by 9 analysts with an average price target of $13.87. This is a potential upside of $12.43 (863.19%) from yesterday's end of day stock price of $1.44.
Marinus Pharmaceuticals's activity chart (see below) currently has 46 price targets and 62 ratings on display. The stock rating distribution of MRNS is 93.75% BUY and 6.25% HOLD.
Analysts average stock forecasts to be materialized ratio is 5.83% with an average time for these price targets to be met of 44.43 days.
Highest price target for MRNS is $28, Lowest price target is $3, average price target is $13.87.
Most recent stock forecast was given by BRIAN ABRAHAMS from RBC on 15-Apr-2024.
Currently out of the existing stock ratings of MRNS, 30 are a BUY (93.75%), 2 are a HOLD (6.25%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
3
$1.56 (108.33%)
21
10 days ago
2/10 (20%)
$1.7 (130.77%)
247
Buy
27
$25.56 (1775.00%)
27
30 days ago
0/11 (0%)
$18.21 (207.17%)
Hold
9
$7.56 (525.00%)
14
1 months 18 days ago
1/5 (20%)
$0.25 (2.86%)
5
Buy
13
$11.56 (802.78%)
15
5 months 17 days ago
1/6 (16.67%)
$6.1 (88.41%)
309
Buy
25
$16.25 (185.71%)
32
5 months 17 days ago
0/9 (0%)
$18.1 (262.32%)
What is MRNS (Marinus Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on MRNS (Marinus Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on MRNS (Marinus Pharmaceuticals)?
Which analyst is the currently most bullish on MRNS (Marinus Pharmaceuticals)?
Which analyst is the currently most reserved on MRNS (Marinus Pharmaceuticals)?
